Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
That's according to a recent survey from Evercore ISI that focused on GLP-1s, which include Novo Nordisk's weight loss injection Wegovy and diabetes counterpart Ozempic
Presented for research literature review only Feldman-Billard S (2024)
Other efficacy outcomes at 104 weeks included: A 40% reduction in uACR with semaglutide versus 12% with placebo
This is the same active ingredient as Wegovy, but Ozempic is approved for type 2 diabetes and is not interchangeable with Wegovy
Retatrutide itself is still being studied, but approved incretin therapies can require careful glucose monitoring when used with diabetes medications that lower blood sugar
US$ 27.85
US$ 21.28
US$ 27.96
